ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Allogeneic Stem Cell Therapy Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-34M13380
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Allogeneic Stem Cell Therapy Market Research Report 2023
BUY CHAPTERS

Global Allogeneic Stem Cell Therapy Market Research Report 2025

Code: QYRE-Auto-34M13380
Report
June 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Escape Therapeutics Inc
Lonza Group Ltd
Osiris Therapeutics (Smith & Nephew)
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
PHARMICELL
ANTEROGEN CO LTD
Molmed
Takeda (TiGenix)

Allogeneic Stem Cell Therapy Market Size

The global market for Allogeneic Stem Cell Therapy was valued at US$ 906 million in the year 2024 and is projected to reach a revised size of US$ 1793 million by 2031, growing at a CAGR of 10.4% during the forecast period.

Allogeneic Stem Cell Therapy Market

Allogeneic Stem Cell Therapy Market

North American market for Allogeneic Stem Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Allogeneic Stem Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Allogeneic Stem Cell Therapy in Musculoskeletal Disorder is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Allogeneic Stem Cell Therapy include Escape Therapeutics, Inc., Lonza Group Ltd., Osiris Therapeutics (Smith & Nephew), NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Anterogen, MolMed S.p.A., Takeda (TiGenix), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Allogeneic Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allogeneic Stem Cell Therapy.
The Allogeneic Stem Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Allogeneic Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allogeneic Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Allogeneic Stem Cell Therapy Market Report

Report Metric Details
Report Name Allogeneic Stem Cell Therapy Market
Accounted market size in year US$ 906 million
Forecasted market size in 2031 US$ 1793 million
CAGR 10.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Musculoskeletal Disorder
  • Wounds & Injuries
  • Cardiovascular Diseases
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Escape Therapeutics, Inc., Lonza Group Ltd., Osiris Therapeutics (Smith & Nephew), NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Anterogen, MolMed S.p.A., Takeda (TiGenix)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Allogeneic Stem Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Allogeneic Stem Cell Therapy Market growing?

Ans: The Allogeneic Stem Cell Therapy Market witnessing a CAGR of 10.4% during the forecast period 2025-2031.

What is the Allogeneic Stem Cell Therapy Market size in 2031?

Ans: The Allogeneic Stem Cell Therapy Market size in 2031 will be US$ 1793 million.

Who are the main players in the Allogeneic Stem Cell Therapy Market report?

Ans: The main players in the Allogeneic Stem Cell Therapy Market are Escape Therapeutics, Inc., Lonza Group Ltd., Osiris Therapeutics (Smith & Nephew), NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Anterogen, MolMed S.p.A., Takeda (TiGenix)

What are the Application segmentation covered in the Allogeneic Stem Cell Therapy Market report?

Ans: The Applications covered in the Allogeneic Stem Cell Therapy Market report are Musculoskeletal Disorder, Wounds & Injuries, Cardiovascular Diseases, Others

What are the Type segmentation covered in the Allogeneic Stem Cell Therapy Market report?

Ans: The Types covered in the Allogeneic Stem Cell Therapy Market report are Adult Stem Cell Therapy, Human Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Others

Recommended Reports

Cell Therapy Markets

Stem Cell Related

Hematological Diseases

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allogeneic Stem Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Adult Stem Cell Therapy
1.2.3 Human Embryonic Stem Cell Therapy
1.2.4 Induced Pluripotent Stem Cell Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Allogeneic Stem Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Musculoskeletal Disorder
1.3.3 Wounds & Injuries
1.3.4 Cardiovascular Diseases
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Allogeneic Stem Cell Therapy Market Perspective (2020-2031)
2.2 Global Allogeneic Stem Cell Therapy Growth Trends by Region
2.2.1 Global Allogeneic Stem Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Allogeneic Stem Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Allogeneic Stem Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Allogeneic Stem Cell Therapy Market Dynamics
2.3.1 Allogeneic Stem Cell Therapy Industry Trends
2.3.2 Allogeneic Stem Cell Therapy Market Drivers
2.3.3 Allogeneic Stem Cell Therapy Market Challenges
2.3.4 Allogeneic Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allogeneic Stem Cell Therapy Players by Revenue
3.1.1 Global Top Allogeneic Stem Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Allogeneic Stem Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Allogeneic Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Allogeneic Stem Cell Therapy Revenue
3.4 Global Allogeneic Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Allogeneic Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allogeneic Stem Cell Therapy Revenue in 2024
3.5 Global Key Players of Allogeneic Stem Cell Therapy Head office and Area Served
3.6 Global Key Players of Allogeneic Stem Cell Therapy, Product and Application
3.7 Global Key Players of Allogeneic Stem Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Allogeneic Stem Cell Therapy Breakdown Data by Type
4.1 Global Allogeneic Stem Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Allogeneic Stem Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Allogeneic Stem Cell Therapy Breakdown Data by Application
5.1 Global Allogeneic Stem Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Allogeneic Stem Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Allogeneic Stem Cell Therapy Market Size (2020-2031)
6.2 North America Allogeneic Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Allogeneic Stem Cell Therapy Market Size by Country (2020-2025)
6.4 North America Allogeneic Stem Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Allogeneic Stem Cell Therapy Market Size (2020-2031)
7.2 Europe Allogeneic Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Allogeneic Stem Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Allogeneic Stem Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Allogeneic Stem Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Allogeneic Stem Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Allogeneic Stem Cell Therapy Market Size (2020-2031)
9.2 Latin America Allogeneic Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Allogeneic Stem Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Allogeneic Stem Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allogeneic Stem Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Allogeneic Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Escape Therapeutics, Inc.
11.1.1 Escape Therapeutics, Inc. Company Details
11.1.2 Escape Therapeutics, Inc. Business Overview
11.1.3 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Introduction
11.1.4 Escape Therapeutics, Inc. Revenue in Allogeneic Stem Cell Therapy Business (2020-2025)
11.1.5 Escape Therapeutics, Inc. Recent Development
11.2 Lonza Group Ltd.
11.2.1 Lonza Group Ltd. Company Details
11.2.2 Lonza Group Ltd. Business Overview
11.2.3 Lonza Group Ltd. Allogeneic Stem Cell Therapy Introduction
11.2.4 Lonza Group Ltd. Revenue in Allogeneic Stem Cell Therapy Business (2020-2025)
11.2.5 Lonza Group Ltd. Recent Development
11.3 Osiris Therapeutics (Smith & Nephew)
11.3.1 Osiris Therapeutics (Smith & Nephew) Company Details
11.3.2 Osiris Therapeutics (Smith & Nephew) Business Overview
11.3.3 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Introduction
11.3.4 Osiris Therapeutics (Smith & Nephew) Revenue in Allogeneic Stem Cell Therapy Business (2020-2025)
11.3.5 Osiris Therapeutics (Smith & Nephew) Recent Development
11.4 NuVasive
11.4.1 NuVasive Company Details
11.4.2 NuVasive Business Overview
11.4.3 NuVasive Allogeneic Stem Cell Therapy Introduction
11.4.4 NuVasive Revenue in Allogeneic Stem Cell Therapy Business (2020-2025)
11.4.5 NuVasive Recent Development
11.5 Chiesi Pharmaceuticals
11.5.1 Chiesi Pharmaceuticals Company Details
11.5.2 Chiesi Pharmaceuticals Business Overview
11.5.3 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Introduction
11.5.4 Chiesi Pharmaceuticals Revenue in Allogeneic Stem Cell Therapy Business (2020-2025)
11.5.5 Chiesi Pharmaceuticals Recent Development
11.6 JCR Pharmaceutical
11.6.1 JCR Pharmaceutical Company Details
11.6.2 JCR Pharmaceutical Business Overview
11.6.3 JCR Pharmaceutical Allogeneic Stem Cell Therapy Introduction
11.6.4 JCR Pharmaceutical Revenue in Allogeneic Stem Cell Therapy Business (2020-2025)
11.6.5 JCR Pharmaceutical Recent Development
11.7 Pharmicell
11.7.1 Pharmicell Company Details
11.7.2 Pharmicell Business Overview
11.7.3 Pharmicell Allogeneic Stem Cell Therapy Introduction
11.7.4 Pharmicell Revenue in Allogeneic Stem Cell Therapy Business (2020-2025)
11.7.5 Pharmicell Recent Development
11.8 Anterogen
11.8.1 Anterogen Company Details
11.8.2 Anterogen Business Overview
11.8.3 Anterogen Allogeneic Stem Cell Therapy Introduction
11.8.4 Anterogen Revenue in Allogeneic Stem Cell Therapy Business (2020-2025)
11.8.5 Anterogen Recent Development
11.9 MolMed S.p.A.
11.9.1 MolMed S.p.A. Company Details
11.9.2 MolMed S.p.A. Business Overview
11.9.3 MolMed S.p.A. Allogeneic Stem Cell Therapy Introduction
11.9.4 MolMed S.p.A. Revenue in Allogeneic Stem Cell Therapy Business (2020-2025)
11.9.5 MolMed S.p.A. Recent Development
11.10 Takeda (TiGenix)
11.10.1 Takeda (TiGenix) Company Details
11.10.2 Takeda (TiGenix) Business Overview
11.10.3 Takeda (TiGenix) Allogeneic Stem Cell Therapy Introduction
11.10.4 Takeda (TiGenix) Revenue in Allogeneic Stem Cell Therapy Business (2020-2025)
11.10.5 Takeda (TiGenix) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Escape Therapeutics Inc
Lonza Group Ltd
Osiris Therapeutics (Smith & Nephew)
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
PHARMICELL
ANTEROGEN CO LTD
Molmed
Takeda (TiGenix)
List of Tables
 Table 1. Global Allogeneic Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Adult Stem Cell Therapy
 Table 3. Key Players of Human Embryonic Stem Cell Therapy
 Table 4. Key Players of Induced Pluripotent Stem Cell Therapy
 Table 5. Key Players of Others
 Table 6. Global Allogeneic Stem Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Allogeneic Stem Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Allogeneic Stem Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Allogeneic Stem Cell Therapy Market Share by Region (2020-2025)
 Table 10. Global Allogeneic Stem Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Allogeneic Stem Cell Therapy Market Share by Region (2026-2031)
 Table 12. Allogeneic Stem Cell Therapy Market Trends
 Table 13. Allogeneic Stem Cell Therapy Market Drivers
 Table 14. Allogeneic Stem Cell Therapy Market Challenges
 Table 15. Allogeneic Stem Cell Therapy Market Restraints
 Table 16. Global Allogeneic Stem Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Allogeneic Stem Cell Therapy Market Share by Players (2020-2025)
 Table 18. Global Top Allogeneic Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allogeneic Stem Cell Therapy as of 2024)
 Table 19. Ranking of Global Top Allogeneic Stem Cell Therapy Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Allogeneic Stem Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Allogeneic Stem Cell Therapy, Headquarters and Area Served
 Table 22. Global Key Players of Allogeneic Stem Cell Therapy, Product and Application
 Table 23. Global Key Players of Allogeneic Stem Cell Therapy, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Allogeneic Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Allogeneic Stem Cell Therapy Revenue Market Share by Type (2020-2025)
 Table 27. Global Allogeneic Stem Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Allogeneic Stem Cell Therapy Revenue Market Share by Type (2026-2031)
 Table 29. Global Allogeneic Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Allogeneic Stem Cell Therapy Revenue Market Share by Application (2020-2025)
 Table 31. Global Allogeneic Stem Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Allogeneic Stem Cell Therapy Revenue Market Share by Application (2026-2031)
 Table 33. North America Allogeneic Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Allogeneic Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Allogeneic Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Allogeneic Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Allogeneic Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Allogeneic Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Allogeneic Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Allogeneic Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Allogeneic Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Allogeneic Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Allogeneic Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Escape Therapeutics, Inc. Company Details
 Table 49. Escape Therapeutics, Inc. Business Overview
 Table 50. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Product
 Table 51. Escape Therapeutics, Inc. Revenue in Allogeneic Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 52. Escape Therapeutics, Inc. Recent Development
 Table 53. Lonza Group Ltd. Company Details
 Table 54. Lonza Group Ltd. Business Overview
 Table 55. Lonza Group Ltd. Allogeneic Stem Cell Therapy Product
 Table 56. Lonza Group Ltd. Revenue in Allogeneic Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 57. Lonza Group Ltd. Recent Development
 Table 58. Osiris Therapeutics (Smith & Nephew) Company Details
 Table 59. Osiris Therapeutics (Smith & Nephew) Business Overview
 Table 60. Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Product
 Table 61. Osiris Therapeutics (Smith & Nephew) Revenue in Allogeneic Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 62. Osiris Therapeutics (Smith & Nephew) Recent Development
 Table 63. NuVasive Company Details
 Table 64. NuVasive Business Overview
 Table 65. NuVasive Allogeneic Stem Cell Therapy Product
 Table 66. NuVasive Revenue in Allogeneic Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 67. NuVasive Recent Development
 Table 68. Chiesi Pharmaceuticals Company Details
 Table 69. Chiesi Pharmaceuticals Business Overview
 Table 70. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Product
 Table 71. Chiesi Pharmaceuticals Revenue in Allogeneic Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 72. Chiesi Pharmaceuticals Recent Development
 Table 73. JCR Pharmaceutical Company Details
 Table 74. JCR Pharmaceutical Business Overview
 Table 75. JCR Pharmaceutical Allogeneic Stem Cell Therapy Product
 Table 76. JCR Pharmaceutical Revenue in Allogeneic Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 77. JCR Pharmaceutical Recent Development
 Table 78. Pharmicell Company Details
 Table 79. Pharmicell Business Overview
 Table 80. Pharmicell Allogeneic Stem Cell Therapy Product
 Table 81. Pharmicell Revenue in Allogeneic Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 82. Pharmicell Recent Development
 Table 83. Anterogen Company Details
 Table 84. Anterogen Business Overview
 Table 85. Anterogen Allogeneic Stem Cell Therapy Product
 Table 86. Anterogen Revenue in Allogeneic Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 87. Anterogen Recent Development
 Table 88. MolMed S.p.A. Company Details
 Table 89. MolMed S.p.A. Business Overview
 Table 90. MolMed S.p.A. Allogeneic Stem Cell Therapy Product
 Table 91. MolMed S.p.A. Revenue in Allogeneic Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 92. MolMed S.p.A. Recent Development
 Table 93. Takeda (TiGenix) Company Details
 Table 94. Takeda (TiGenix) Business Overview
 Table 95. Takeda (TiGenix) Allogeneic Stem Cell Therapy Product
 Table 96. Takeda (TiGenix) Revenue in Allogeneic Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 97. Takeda (TiGenix) Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Allogeneic Stem Cell Therapy Picture
 Figure 2. Global Allogeneic Stem Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Allogeneic Stem Cell Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Adult Stem Cell Therapy Features
 Figure 5. Human Embryonic Stem Cell Therapy Features
 Figure 6. Induced Pluripotent Stem Cell Therapy Features
 Figure 7. Others Features
 Figure 8. Global Allogeneic Stem Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Allogeneic Stem Cell Therapy Market Share by Application: 2024 VS 2031
 Figure 10. Musculoskeletal Disorder Case Studies
 Figure 11. Wounds & Injuries Case Studies
 Figure 12. Cardiovascular Diseases Case Studies
 Figure 13. Others Case Studies
 Figure 14. Allogeneic Stem Cell Therapy Report Years Considered
 Figure 15. Global Allogeneic Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Allogeneic Stem Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Allogeneic Stem Cell Therapy Market Share by Region: 2024 VS 2031
 Figure 18. Global Allogeneic Stem Cell Therapy Market Share by Players in 2024
 Figure 19. Global Top Allogeneic Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allogeneic Stem Cell Therapy as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Allogeneic Stem Cell Therapy Revenue in 2024
 Figure 21. North America Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Allogeneic Stem Cell Therapy Market Share by Country (2020-2031)
 Figure 23. United States Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Allogeneic Stem Cell Therapy Market Share by Country (2020-2031)
 Figure 27. Germany Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Allogeneic Stem Cell Therapy Market Share by Region (2020-2031)
 Figure 35. China Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Allogeneic Stem Cell Therapy Market Share by Country (2020-2031)
 Figure 43. Mexico Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Allogeneic Stem Cell Therapy Market Share by Country (2020-2031)
 Figure 47. Turkey Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Allogeneic Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Escape Therapeutics, Inc. Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2020-2025)
 Figure 51. Lonza Group Ltd. Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2020-2025)
 Figure 52. Osiris Therapeutics (Smith & Nephew) Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2020-2025)
 Figure 53. NuVasive Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2020-2025)
 Figure 54. Chiesi Pharmaceuticals Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2020-2025)
 Figure 55. JCR Pharmaceutical Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2020-2025)
 Figure 56. Pharmicell Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2020-2025)
 Figure 57. Anterogen Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2020-2025)
 Figure 58. MolMed S.p.A. Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2020-2025)
 Figure 59. Takeda (TiGenix) Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Allogeneic Bone Graft Market Research Report 2024
Stem Cell Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hematopoietic Progenitor Cells Transplantation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Allogeneic Bone Implant Materials Market Research Report 2025
Global Liver Stem Cell Therapy Market Research Report 2024
Cancer Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Allogeneic Bone Graft Substitutes Market Research Report 2024
Global Stem Cell Source Market Research Report 2024
Plant Based Stem Cell Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cardiac Disease Stem Cell Therapy Market Research Report 2024
Global Cellular Allografts Market Research Report 2024
Global Stem Cell Equipment Market Research Report 2024
Global Cell Therapy Manufacturing Market Research Report 2025
Hadron Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cell Processing Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hematopoietic Stem Cell Transplantation HSCT Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Autologous Stem Cell and Non Stem Cell Based Therapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adult Stem Cell Storage Market Research Report 2025
Bone Marrow Collection Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viable Cell Allograft Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions